News
Publications
Multimedia
Conferences
Webcasts
Resources
Subscribe

Spotlight -

Drug Development|

Quality Systems

Opinion|Videos|January 9, 2024

Identifying the Right CDMO to Support Biopharma Manufacturing

Author(s)Ascendia Pharma

Episodes in this series

Ascendia Pharmaceuticals, Jeanne Linke Northrop, Pharmaceutical Technology

EP. 1 New Opportunities via Novel Formulation Technologies

Pharmaceutical Technology, Ascendia Pharma

EP. 2 Identifying the Right CDMO to Support Biopharma Manufacturing

Ascendia Pharmaceutical, Pharmaceutical Technology

EP. 3 Optimizing Drug Delivery Methods With Nanotechnologies

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals discusses:

What to look for when identifying a CDMO for a drug development project
Ascendia Pharmaceuticals and its expansion of manufacturing services
Ascendia Pharmaceuticals as a "Partner of Choice"

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Trending on Pharmaceutical Technology

GSK Acquires Nuvalent for $10.6 Billion in Lung Cancer Push

USP Reports Drug Discontinuations on the Rise

Patient Access to Radiopharmaceuticals

Why Big Pharma Is Betting Billions on Protein Degraders for Cancer

Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines